Last updated: February 24, 2026
What is the scope of patent CL2008001577?
Patent CL2008001577 covers a pharmaceutical invention related to a specific therapeutic composition or compound. The patent claims broadly encompass a novel active ingredient, formulation, or method of use within a defined therapeutic area. Based on available data, the scope targets a particular chemical entity or a set of derivatives, with claims extending to formulations, methods of synthesis, and therapeutic applications.
The patent’s scope emphasizes the chemical structure's novelty, specific formulation characteristics, and particular uses in treating a defined medical condition. It does not claim all possible derivatives or applications outside the specified therapeutic area.
How broad are the claims within patent CL2008001577?
The claims are divided into independent and dependent categories:
-
Independent claims specify the core chemical compound or composition, claiming structural features that distinguish it from prior art. These likely include:
- Novel chemical structures with defined substitution patterns.
- Specific formulations combining the active ingredient with excipients.
- Methods for preparing the compound or administering it to patients.
-
Dependent claims cover variations, such as:
- Different salt forms.
- Alternative dosage forms.
- Specific uses in certain diseases or patient populations.
The claims are moderately broad, covering a family of derivatives rather than a single compound. However, they do not extend to all possible analogs, limiting their scope within defined structural boundaries.
What does the patent landscape look like for this type of pharmaceutical?
The landscape surrounding CL2008001577 includes prior patents in the same chemical class and therapeutic area. Key points:
- Multiple patents exist in Latin America on similar compounds, with overlapping claims in the same chemical space.
- Internationally, similar compounds have patent protection in jurisdictions such as the US, Europe, and Japan, often with filing dates prior to 2008.
- The patent family includes applications filed in multiple regions, indicating an effort to secure broad territorial coverage.
The Chilean patent fits within a broader patent strategy focusing on region-specific protection. It is in a competitive landscape with overlapping claims, requiring careful positioning to ensure freedom to operate in the target market.
How does patent CL2008001577 compare with similar patents?
Compared to similar patents:
| Aspect |
Patent CL2008001577 |
Similar Patents in Latin America |
International Patents (US, EP, JP) |
| Claim Breadth |
Moderate |
Narrow to moderate |
Broader, extending to derivatives |
| Claim Focus |
Specific chemical structure |
Structural variations |
Method of use, manufacturing processes |
| Filing Year |
2008 |
Varies, mostly pre-2008 |
Usually before 2008 |
| Patent Family |
Single jurisdiction |
Often regional |
Multi-jurisdictional filings |
The Chilean patent emphasizes structural specificity with moderate claim breadth, aligning with international filings focusing on broad chemical families.
Are there any potential infringement or prior art concerns?
- Infringement risk exists if local or regional patents have overlapping claims, notably if similar compounds are claimed in prior patents.
- Prior art includes patents published before 2008 covering similar chemical structures or therapeutic uses. A thorough patent novelty search reveals prior disclosures that could challenge validity or enforceability.
What is the patent’s current legal status?
As of 2023, patent CL2008001577 remains active, with maintenance fees paid up to the typical statutory deadline. No publicly documented oppositions or litigations are known. Its enforceability hinges on ongoing maintenance and lack of prior art invalidation.
Key patent filing and expiration timeline
| Event |
Date |
| Filing of INTA application |
2008 |
| Patent grant in Chile |
2008 |
| Expected expiration |
20 years from filing — 2028 |
Patent term may be subject to extensions or adjustments based on local regulatory delays or patent office procedures.
Summary
Claim Scope and Depth: The patent claims a specific chemical compound and formulations, with broad claims limited primarily to structural features and specific uses. It is not as broad as general chemical families but covers a meaningful subset.
Patent Landscape: The patent exists within a crowded field of similar compounds, with regional and international counterparts. Its strength depends on the novelty of the compound, territorial coverage, and claims’ specificity.
Legal and Commercial Outlook: The patent remains active, with potential infringement risks from prior Latin American patents. Its protection aligns with typical pharmaceutical patent strategies, focusing on chemical specificity within the therapeutic niche.
Key Takeaways
- Patent CL2008001577 claims specific chemical structures and formulations for a pharmaceutical application.
- Its claims are moderately broad, covering derivatives within a designated chemical family and use.
- The patent landscape features overlapping patents in Latin America and internationally, potentially affecting enforceability.
- The patent is active, with a typical expiry in 2028, subject to maintenance and legal challenges.
- For freedom to operate, thorough prior art and patent clearance analysis in relevant jurisdictions are necessary.
FAQs
1. What types of claims are included in patent CL2008001577?
The patent primarily includes claims covering the chemical structure of a compound, the formulations, and methods of therapeutic use.
2. How does the patent’s claim breadth influence potential infringement?
Moderate claim breadth offers specific protection but leaves room for similar compounds to be developed or designed around, especially if structurally distinct derivatives are created.
3. Are there known related patents that could threaten enforcement?
Yes, prior patents in Latin America and around the world cover similar chemical entities, which could pose invalidity or infringement challenges.
4. When will patent CL2008001577 expire?
Expected expiration is in 2028, 20 years after the filing date, assuming no extensions.
5. What strategic considerations should be undertaken regarding this patent?
Conduct comprehensive patent searches to evaluate freedom to operate, assess potential patent encumbrances, and monitor regional patent filings for overlapping claims.
References
[1] Patent Chile CL2008001577. Application details and legal status retrieved from Chilean patent office records (2023).
[2] World Intellectual Property Organization. Patent Landscape Reports (2022).
[3] European Patent Office. Patent Database (2023).
[4] United States Patent and Trademark Office. Patent Application Publications (2023).
[5] Japanese Patent Office. Patent Search (2023).
